For research use only. Not for therapeutic Use.
Sebetralstat (KVD900) is a plasma kallikrein inhibitor (WO2016083820). Sebetralstat can be used for the research of metabolic diseases[1].
Sebetralstat is a plasma kallikrein inhibitor[1].
| Catalog Number | I036172 |
| CAS Number | 1933514-13-6 |
| Synonyms | N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-[[4-[(2-oxopyridin-1-yl)methyl]phenyl]methyl]pyrazole-4-carboxamide |
| Molecular Formula | C26H26FN5O4 |
| Purity | ≥95% |
| InChI | InChI=1S/C26H26FN5O4/c1-35-17-22-20(26(34)29-13-21-25(27)23(36-2)10-11-28-21)16-32(30-22)15-19-8-6-18(7-9-19)14-31-12-4-3-5-24(31)33/h3-12,16H,13-15,17H2,1-2H3,(H,29,34) |
| InChIKey | KGMPDQIYDKKXRD-UHFFFAOYSA-N |
| SMILES | COCC1=NN(C=C1C(=O)NCC2=NC=CC(=C2F)OC)CC3=CC=C(C=C3)CN4C=CC=CC4=O |
| Reference | [1]. WO2016083820 |
